PR9-F Stock Overview

Engages in hospital operations primarily in Thailand. More details

PR9-F fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	5/6
Financial Health	6/6
Dividends	2/6

Rewards

Trading at 3.1% below our estimate of its fair value

Earnings are forecast to grow 11.73% per year

Earnings grew by 41.3% over the past year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Praram 9 Hospital Public Company Limited Competitors

Master Style

SET:MASTER

฿13.7b

Sikarin

SET:SKR

฿19.3b

Wattanapat Hospital Trang

SET:WPH

฿6.0b

Vibhavadi Medical Center

SET:VIBHA

฿26.4b

Price History & Performance

Summary of share price highs, lows and changes for Praram 9 Hospital
Historical stock prices
Current Share Price	฿18.90
52 Week High	฿19.00
52 Week Low	฿18.90
Beta	0.23
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	58.82%

Recent updates

Shareholder Returns

	PR9-F	TH Healthcare	TH Market
7D	0%	2.9%	2.7%
1Y	n/a	-16.6%	-1.6%

Return vs Industry: Insufficient data to determine how PR9-F performed against the TH Healthcare industry.

Return vs Market: Insufficient data to determine how PR9-F performed against the TH Market.

Price Volatility

Is PR9-F's price volatile compared to industry and market?
PR9-F volatility
PR9-F Average Weekly Movement	n/a
Healthcare Industry Average Movement	4.0%
Market Average Movement	4.3%
10% most volatile stocks in TH Market	8.8%
10% least volatile stocks in TH Market	2.1%

Stable Share Price: PR9-F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PR9-F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1992	n/a	Satian Pooprasert	www.praram9.com

Praram 9 Hospital Public Company Limited operates a hospital under the Praram 9 Hospital name in Thailand. The company operates medicine, surgery, diabetes and metabolic, spine, neurology, thyroid and thyroid surgery, obstetrics gynecology, IVF, oncocare, emergency, imaging, LASIK, skin and cosmetic laser surgery, mind, gastroenterology and hepatobiliary, dental, check-up, eye, pediatric, sleep, ear, nose, and throat centers, as well as breast, and vaccination and travel medicine clinics. It is also involved in the operation of kidney disease and transplantation, cardiovascular, and pain management and wellness institutes.

Praram 9 Hospital Public Company Limited Fundamentals Summary

How do Praram 9 Hospital's earnings and revenue compare to its market cap?
PR9-F fundamental statistics
Market cap	฿14.00b
Earnings (TTM)	฿519.38m
Revenue (TTM)	฿4.14b

26.9x

P/E Ratio

3.4x

P/S Ratio

Is PR9-F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PR9-F income statement (TTM)
Revenue	฿4.14b
Cost of Revenue	฿2.75b
Gross Profit	฿1.39b
Other Expenses	฿867.22m
Earnings	฿519.38m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0.66
Gross Margin	33.50%
Net Profit Margin	12.55%
Debt/Equity Ratio	0%

How did PR9-F perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

44%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/07/16 17:01
End of Day Share Price	2023/04/18 00:00
Earnings	2023/03/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Praram 9 Hospital Public Company Limited is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Charti Phrawphraikul	BofA Global Research
Narumon Ekasamut	Bualuang Securities PCL
Panjapon Taensricharoen	Bualuang Securities PCL

Praram 9 Hospital THAMSE:PR9-F Stock Report